Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,240 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06610760RecruitingPhase 4
Ursodeoxycholic acid for stomach precancer reversal
This trial tests if ursodeoxycholic acid can reverse intestinal metaplasia (a precancerous stomach condition) in patients who have no H. pylori infection. The goal is to see if this medication can help lower the risk of stomach cancer.
Pingdingshan, HenanAges 18–75 - NCT07423910Recruiting
Numbing injections for better recovery after hernia surgery
This study looks at two types of numbing injections (TAP and RS blocks) to see which helps people recover better after groin hernia surgery. If you are having a planned single-side hernia repair, you might qualify to join.
TampereAges 18 years+ - NCT06609603Recruiting
Study on green tea extract for reducing body fat
This study tests whether a special heat-treated green tea extract can help reduce body fat in people with overweight or obesity. It involves taking the extract daily for a period and checking changes in your body composition.
Suwon, Gyeonggi-doAges 19–64 - NCT05912517RecruitingPhase 3
Nipocalimab for high-risk pregnancy blood disease
This Phase 3 trial tests nipocalimab (an antibody medicine) to help prevent severe blood breakdown in a baby when a parent has certain blood antibodies. It enrolls people who previously had severe hemolytic disease in a past pregnancy and who are currently early in pregnancy with the same risk antibodies.
La Jolla, CaliforniaAges 18–45 - NCT07220252RecruitingPhase 2/Phase 3
Ublituximab for children with relapsing multiple sclerosis
This trial tests a new drug called ublituximab to see if it can reduce flare-ups in children and teens who have relapsing multiple sclerosis. It aims to understand if the treatment is safe and effective for younger patients.
GdanskAges 10–17 - NCT06985394Recruiting
Blood vessel health and stress in emergency responders
This study looks at how shift work affects blood vessel function and oxidative stress in emergency medical responders. It may help understand why first responders have higher risk for heart problems.
Newark, DelawareAges 20–40 - NCT06588855RecruitingPhase 3
Study of afimkibart for moderate to severe ulcerative colitis
This trial is testing a new medication called afimkibart (RO7790121) for people with moderate to severe ulcerative colitis. It aims to see if this treatment can help reduce inflammation and improve symptoms in people who haven't had success with other therapies.
Dothan, AlabamaAges 16–80 - NCT06592365Recruiting
Green tea extract for blood sugar control
This trial tests whether a green tea extract can help regulate blood sugar levels in people with mildly elevated fasting glucose. If you are between 19 and 64, have a BMI under 30, and have not been diagnosed with diabetes, you may be able to join.
SeoulAges 19–64 - NCT06590454RecruitingPhase 2
Reversing stomach lining changes to lower cancer risk
This trial tests whether a treatment can reverse stomach lining changes called GIM that increase cancer risk. It's for people who have had a past H. pylori infection but no current stomach cancer, and whose GIM has certain high-risk features.
Durham, North CarolinaAges 18 years+ - NCT06589128Recruiting
Eye product for digital eye strain in children
This study tests an eye product to see if it helps relieve digital eye strain (sore, tired, or dry eyes from screens) in children. It is for kids who have mild to moderate symptoms from using digital devices.
Kepala Batas, Pulau PinangAges 10–11 - NCT06266715Recruiting
Testing ATP for depression relief
This trial tests if a natural compound called ATP can help improve moderate to severe depression symptoms. If you haven't taken antidepressants recently and have never tried escitalopram, you may be eligible.
Guangzhou, GuangdongAges 18–65 - NCT07363057RecruitingPhase 2
Study of GI-102 and GIB-7 for aging in healthy adults and cancer survivors
This trial tests whether a combination of two drugs, GI-102 and GIB-7, can affect markers of aging in healthy people and in people who have had cancer. It aims to see if these drugs might help slow or improve aging-related changes.
Charlestown, New South WalesAges 18–80 - NCT06919718Recruiting
Vitamin D supplements for new mothers in Idaho
This trial tests whether taking vitamin D supplements can improve mental health and change the nutrients in breast milk for mothers living in Idaho.
Coeur d'Alene, IdahoAges 18–64 - NCT07415707Recruiting
Reducing alcohol and taking probiotics for brain health in older adults
This study tests whether cutting back on alcohol and taking probiotics can improve memory and thinking in older adults who are heavy drinkers. If you are interested in drinking less, you may be able to join.
Miami, FloridaAges 65–84 - NCT07202000RecruitingPhase 2
Exercise and a drug to reduce inflammation for heart failure with preserved ejection fraction
This trial tests whether combining exercise with a medication that blocks a protein called activin can reduce inflammation, improve heart function, and help with thinking in people with heart failure with preserved ejection fraction (HFpEF).
Boston, MassachusettsAges 40 years+ - NCT04036188RecruitingEarly Phase 1
Vitamin D and triamcinolone for plaque psoriasis
This early study tests whether taking vitamin D together with triamcinolone (a steroid used on skin) works better for plaque psoriasis than a standard approach. It aims to see if the combination helps clear psoriasis plaques and is safe.
Fairborn, OhioAges 18 years+ - NCT07401212Recruiting
Fiber-boosting program for parents of preschoolers
This study tests a program to help parents add more fiber to their preschooler's diet. It may be a good fit if your child eats less fiber than recommended and is generally healthy.
Reading, BerkshireAges 3–5 - NCT07356713RecruitingPhase 1
Finding the right dose of EXL-111 for healthy volunteers
This trial tests a new drug called EXL-111 in healthy people to find the safest and best dose for future studies. It may help people with allergies if the drug proves effective.
Adelaide, South AustraliaAges 18–55 - NCT06575400RecruitingPhase 1
Testing tolerance of BI 3804379 in healthy people and MASH patients
This study tests how well different doses of a new drug (BI 3804379) are tolerated. It is for healthy people and for patients with MASH (a type of fatty liver disease) who have advanced liver scarring.
EdegemAges 18–65 - NCT07402382Recruiting
Chromium blend study for women in menopause transition
This trial tests whether a special chromium supplement can help the body process protein and sugar better in women going through or past menopause. You'll follow a controlled diet and have blood draws to measure how your body responds.
Canfield, OhioAges 40–70 - NCT03972124RecruitingPhase 2
Cannabis to prevent migraine attacks before they start
This Phase 2 trial tests whether using cannabis can prevent migraine attacks from happening. It specifically looks at people with chronic migraine who have tried and not benefited from other prevention medicines.
Calgary, AlbertaAges 25 years+ - NCT06780618Recruiting
Brown rice vs white rice: effects on inflammation in sedentary workers
This study compares eating brown rice versus white rice to see how it affects levels of a molecule linked to inflammation (IL-6) and a marker of cell stress (MDA) in people who sit most of the day for work. If you are a healthy, sedentary office worker, you may help us understand if brown rice can improve your body's health after a meal.
Jakarta, Jakarta Special Capital RegionAges 21–59 - NCT07388576Recruiting
AP-Brain supplement for attention in healthy young adults
This trial tests a supplement called AP-Brain to see if it helps with attention and focus in healthy young adults (ages 18–39) who feel they have attention problems. It compares different doses to find the safest and most effective one.
London, OntarioAges 18–39 - NCT07383974Recruiting
12-week study: how diet affects skin and health
This trial tests whether eating more fruits and vegetables for 12 weeks can improve your skin and how you feel physically. It uses a special light scanner to measure skin health.
Shanghai, Shanghai MunicipalityAges 18 years+
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,240 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.